N-acetylcysteine and Influenza A Viruses
Author Information
Author(s): Mutien-Marie Garigliany, Daniel J Desmecht
Primary Institution: University of Liège, Belgium
Hypothesis
Can N-acetylcysteine (NAC) effectively treat influenza pneumonia caused by different strains of the virus?
Conclusion
N-acetylcysteine is not a universal treatment for influenza pneumonia as its effectiveness varies by virus strain.
Supporting Evidence
- N-acetylcysteine showed a significant but partial anti-influenza effect in vitro.
- Neither percent survival nor body weight loss were altered by NAC treatment in vivo.
- The effectiveness of NAC was found to be strain-dependent.
Takeaway
N-acetylcysteine is a medicine that some thought could help with the flu, but it doesn't work the same for all types of flu viruses.
Methodology
Mice were treated with NAC and observed for survival and weight loss after being infected with a lethal dose of H1N1 virus.
Limitations
The study used a single strain of H1N1 and a specific dose of NAC, which may not represent all strains or dosages.
Participant Demographics
8-week old female CD-1 mice
Statistical Information
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website